Company Monitoring Page for Roche

latest headlines for company on cafepharma

10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
Tags:
clinical trials, Beam Therapeutics, Moderna Therapeutics, Pfizer, Sanofi, Gilead Sciences, JNJ, Amylx, Roche, Alnylam Pharmaceuticals, Vertex Pharmaceuticals
Get ready for the Roche (Remix), ft. a $30M small molecule deal
Fierce Biotech
Wed, 01/3/24 - 09:37 am
Tags:
Roche, Remix Therapeutics, small molecule drugs
Roche Signs Potential $1B ADC Cancer Deal with China’s MediLink
BioSpace
Wed, 01/3/24 - 09:36 am
Tags:
Roche, MediLink Therapeutics, oncology, antibody-drug conjugate
Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche
BioSpace
Tue, 01/2/24 - 11:26 am
Tags:
M&A, AstraZeneca, Gracell Biotechnologies, Bristol Myers Squibb, Rayze Bio, Roche
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI
Motley Fool
Wed, 12/20/23 - 09:31 am
Tags:
Roche, NVIDIA, artificial intelligence, drug development
Roche, Novartis move Xolair closer to FDA finish line for food allergies
Fierce Pharma
Tue, 12/19/23 - 11:10 pm
Tags:
Roche, FDA, Xolair, food allergies, Novartis
Genentech confirms Magargee as permanent CEO
Pharmaphorum
Wed, 12/13/23 - 10:09 pm
Tags:
Roche, Genentech, Pharma CEOs, Ashley Magargee
ASH: Roche offers glimpse of Columvi-Polivy combo's early lymphoma data as phase 3 kicks off
Fierce Pharma
Mon, 12/11/23 - 10:50 pm
Tags:
Roche, ASH 2023, Columvi, Polivy, diffuse large B-cell lymphoma
As ICER places a spotlight on pharma's price hikes, J&J, Roche and more hit back
Fierce Pharma
Mon, 12/11/23 - 10:48 pm
Tags:
ICER, JNJ, Roche, drug pricing
Roche’s Hemlibra shows benefit in Phase III hemophilia A trial
Clinical Trials Arena
Mon, 12/11/23 - 09:57 am
Tags:
Roche, Hemlibra, hemophilia A, clinical trials
Roche reports positive Phase III data for breast cancer therapy
Clinical Trials Arena
Tue, 12/5/23 - 09:56 am
Tags:
Roche, clinical trials, inavolisib, metastatic breast cancer, breast cancer
Genentech's MS drug on partial hold in US after liver enzyme elevations in 2 patients
Fierce Biotech
Mon, 12/4/23 - 06:14 pm
Tags:
Genentech, Roche, MS, multiple sclerosis, fenebrutinib, clinical trials
Roche joins obesity drug chase with $2.7B deal for startup Carmot
BioPharma Dive
Mon, 12/4/23 - 10:18 am
Tags:
Roche, Carmot Therapeutics, weight loss, obesity, M&A
3 standout digital innovations in pharma this year
Pharma Voice
Mon, 12/4/23 - 09:44 am
Tags:
IDEA Pharma, innovation, digital pharma, AstraZeneca, Roche, Boehringer Ingelheim
Roche’s Genentech partners with Nvidia in AI drug deal
BioPharma Dive
Tue, 11/21/23 - 12:00 pm
Tags:
Roche, Genentech, artificial intelligence, NVIDIA
A year after Roche's Alzheimer's failure, scientists reflect on what could have been
Fierce Biotech
Wed, 11/15/23 - 11:49 pm
Tags:
Roche, Genentech, Alzheimer's disease, gantenerumab
European regulator endorses high-dose version of Bayer eye drug Eylea
Reuters
Fri, 11/10/23 - 10:09 am
Tags:
Bayer, EMA, Eylea, Roche
Regeneron touts launch of high-dose Eylea in battle with Roche's Vabysmo
Fierce Pharma
Thu, 11/2/23 - 11:48 am
Tags:
Regeneron, Eylea, Roche, Vabysmo
Roivant’s $7B Roche deal was a ‘moment of opportunity,’ CEO says
BioPharma Dive
Tue, 10/31/23 - 09:32 pm
Tags:
Roivant, Televant, M&A, Roche
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Motley Fool
Sun, 10/29/23 - 08:44 pm
Tags:
Roche, Eli Lilly, Pfizer, IBD, ulcerative colitis, Crohn's Disease, mirikizumab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.